FDA Approves New Melanoma Drug that Turns On the Immune System to Fight Deadly Cancers

A ‘game changer,’ says UCLA’s Dr. Antoni Ribas, the study’s principal investigator.

By Kim Irwin--UCLA News Office | September 07, 2014

Pembrolizumab is the first PD-1 inhibitor that has be approved for the treatment of metastatic melanoma. For more information on this :

http://www.labmanager.com/news/2014/09/fda-approves-new-melanoma-drug-that-turns-on-the-immune-system-to-fight-deadly-cancers#.VBEZAunlrIU